ARTICLE | Clinical News
Cinvanti regulatory update
January 12, 2017 10:15 PM UTC
Heron submitted an NDA to FDA for IV Cinvanti to prevent chemotherapy-induced nausea and vomiting (CINV). The company expects a decision in late 2017. Cinvanti is a polysorbate 80-free formulation of ...
BCIQ Company Profiles